Abstract:Background: Pulmonary hypertension could be associated with pyruvate kinase deficiency (PKD). There are few reported cases of PPHN as the first clinical manifestation of PKD. Herein we report a rare case of PKD in which the patient exhibited persistent pulmonary hypertension in the neonate (PPHN), and genetic testing helped to rapidly identify an potential association. Case presentation: The patient was a newborn boy who suffered from severe dyspnea, extreme anemia, skin pallor, and hypoxemia. Repeated echocardiography indicated persistent severe pulmonary hypertension with a calculated pulmonary artery pressure of 75 mmHg, and right ventricular hypertrophy. The administration of nitric oxide significantly reduced the pulmonary artery pressure. Whole-exome sequencing revealed a compound heterozygous mutation consisting of c.707T > G and c.826_827insAGGAGCATGGGG. PolyPhen_2 and MutationTaster indicated that both the c.707T > G (probability 0.999) and c.826_827insAGGAGCATGGGG (probability 0.998) mutations were disease causing. PROVEAN protein batch analysis indicated that the associated p.L236R region was deleterious (score -4.71) and damaging (SIFT prediction 0.00), and this was also the case for p.G275_V276insEEHG (deleterious score -12.00, SIFT prediction 0.00). Substantial structural changes in the transport domain of the protein were predicted using SWISS-MODEL, and indicated that both mutations led to an unstable protein structure. Thus, a novel compound heterozygous mutation of PKLR-induced PKD with PPHN was diagnosed. Conclusion: The current study suggests that molecular genetic screening is useful for identifying PPHN, particularly in children with metabolic disorders. In patients exhibiting unexplained hyperbilirubinemia combined with severe pulmonary hypertension, PKD might be a potential possible alternative explanation. Genetic screening is helpful for identifying genetic causes of pulmonary hypertension, especially in patients with PPHN. This report expands the mutation spectrum of the PKLR gene, and contributes to the genotype-phenotype map of PKD.

Severe pulmonary arterial hypertension in congenital sideroblastic anemia from PUS1 mutation - a case report

Identification of a Novel Mutation in the BMPR2 Gene in a Pulmonary Arterial Hypertension Patient Using Next‐generation Sequencing

Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy

Proteomic Study Reveals Altered Carbamyl-Phosphate Synthetase I In Congenital Heart Disease-Associated Pulmonary Arterial Hypertension

SOX17 Loss-of-Function Mutation Underlying Familial Pulmonary Arterial Hypertension.

Early identification of SOX17 deficiency in infants to guide management of heritable pulmonary arterial hypertension using PDA stent to create reverse Potts shunt physiology

Pulmonary hypertension in an adult patient with congenital central hypoventilation syndrome: a case report

Case Report: Lethal mitochondrial cardiomyopathy linked to a compound heterozygous variant of PARS2

Molecular genetic framework underlying pulmonary arterial hypertension

A novel and apparent de novo ALAS2 missense variant associated with congenital sideroblastic anemia

Complex heterozygous mutations in hereditary spherocytosis: A case report

Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients

Severe Microcytic Anemia Caused by Complex Hereditary Spherocytosis and X-Linked Sideroblastic Anemia with Mutations in SPTB and ALAS2 Genes

Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

A novel SPTB gene mutation in neonatal hereditary spherocytosis: a case report and literature review

A novel BMPR2 mutation in a patient with heritable pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia: A case report

Abstract 16991: Rare Variants in BMP10 Confer Risk of Pulmonary Arterial Hypertension

Rapid disease progress in a PVOD patient carrying a novel EIF 2 AK 4 mutation: a case report

Pulmonary Capillary Hemangiomatosis as a Rare Underlying Cause of Primary Pulmonary Hypertension: A Case Report in an Adolescent

Luspatercept for the treatment of congenital sideroblastic anemia: two case reports